United Therapeutics reported $7.27 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 7.24 7.16 Nov/04
FY2026Q2 Jun/2026 7.27 7.17 6.41 Aug/05
FY2026Q1 Mar/2026 5.82 6.94 6.63 May/06
FY2025Q4 Dec/2025 7.70 7.07 6.19 Feb/25
FY2025Q3 Sep/2025 7.16 7.43 6.39 Oct/29




Eps Change Date
Amarin USD 0.14 0.06 Dec/2025
Ardelyx USD -0.15 0.15 Mar/2026
Baxter International USD 0.56 0.2 Jun/2026
Bayer EUR 0.95 1.76 Jun/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Biogen USD 3.6 0.03 Jun/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Gilead Sciences USD -6.75 8.78 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Insmed USD -0.76 0.78 Mar/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
Moderna USD -1.97 1.43 Jun/2026
Omeros USD -1.12 0.37 Jun/2024
Pfizer USD 0.77 0.02 Jun/2026
PTC Therapeutics USD 0.92 0.95 Jun/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Teva Pharmaceutical Industries USD 0.06 1.51 Jun/2026
United Therapeutics USD 7.27 1.45 Jun/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026